FCFabiana Maria Coimbra De Carvalho

Fabiana Maria Coimbra De Carvalho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fabiana Maria Coimbra De Carvalho has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy of Carotenoid-Loaded Gelatin Nanoparticles in Reducing Plasma Cytokines and Adipocyte Hypertrophy in Wistar Rats

    by Jaluza Luana C. de Queiroz, Isaiane Medeiros, Mayara S. R. Lima, Fabiana Maria C. de Carvalho, Christina S. Camillo, Pedro Paulo de A. Santos, Gerlane C. B. Guerra, Valéria C. da Silva, Helena T. Schroeder, Mauricio Krause, et al.

    The present study investigated the effect of gelatin-based nanoparticles (EPG) loaded with a carotenoid-rich crude extract (CE) on systemic and adipose tissue inflammatory response in a model with inflammation induced by a high glycemic index and high glycemic load diet (HGLI). Nanoparticles synthesized were characterized by different physical and chemical methods. The in vivo investigation evaluated Wistar rats (n = 20, 11 days, adult male with 21 weeks) subdivided into untreated (HGLI diet), conventional treatment (nutritionally adequate diet), treatment 1 (HGLI + crude extract (12.5 mg/kg)), and treatment 2 (HGLI + EPG (50 mg/kg)) groups. Dietary intake, caloric intake and efficiency, weight, inflammatory cytokines tissue concentration, visceral adipose tissue (VAT) weight, histopathological analysis, and antioxidant activity in plasma and VAT were investigated. EPG showed the same physical and chemical characteristics as previous batches (95.2 nm, smooth surface, and chemical interactions between materials). The EPG-treated group was the only group promoting negative ∆dietary intake, ∆caloric efficiency, and ∆weight. In addition, it presented a significant reduction (p < 0.05) in IL-6 and leptin levels and a greater presence of multilocular adipocytes. The results suggest that EPG can act as a nutraceutical in adjuvant therapy for treating inflammatory diseases associated with adipose tissue accumulation.


  • Tamarind Enzymatic Inhibitors: Activities and Health Application Perspectives

    by F. M. C. D. Carvalho, B. L. L. Maciel, A. H. D. A. Morais

    Tamarind is a fruit with a wide variety of uses, and the presence of enzyme inhibitors in Tamarind seeds gives the fruit bioactive activities. Protease inhibitors have been recognized as molecules that can potentially contribute to health. Trypsin inhibitors present different physiological effects, such as anti-inflammatory and satietogenic effects, which make them potent candidates for the treatment and prevention of chronic diseases, despite the challenging methodologies in characterizing these new molecules. This paper aims to address the activities and health application perspectives of Tamarind enzyme inhibitors using a systematic integrative literature review.


  • Open Access

    Anti-TNF-α Agent Tamarind Kunitz Trypsin Inhibitor Improves Lipid Profile of Wistar Rats Presenting Dyslipidemia and Diet-induced Obesity Regardless of PPAR-γ Induction

    by Fabiana M. C. Carvalho, Vanessa C. O. Lima, Izael S. Costa, Anna B. S. Luz, Fernando V. L. Ladd, Alexandre C. Serquiz, Raul H. Bortolin, Vivian N. Silbiger, Bruna L. L. Maciel, Elizeu A. Santos, et al.

    The increasing prevalence of obesity and, consequently, chronic inflammation and its complications has increased the search for new treatment methods. The effect of the purified tamarind seed trypsin inhibitor (TTIp) on metabolic alterations in Wistar rats with obesity and dyslipidemia was evaluated. Three groups of animals with obesity and dyslipidemia were formed, consuming a high glycemic index and glycemic load (HGLI) diet, for 10 days: Obese/HGLI diet; Obese/standard diet; Obese/HGLI diet + TTIp (730 μg/kg); and one eutrophic group of animals was fed a standard diet. Rats were evaluated daily for food intake and weight gain. On the 11th day, animals were anesthetized and sacrificed for blood and visceral adipose tissue collection. TTIp treated animals presented significantly lower food intake than the untreated group (p = 0.0065), TG (76.20 ± 18.73 mg/dL) and VLDL-C (15.24 ± 3.75 mg/dL). Plasma concentrations and TNF-α mRNA expression in visceral adipose tissue also decreased in obese animals treated with TTIp (p < 0.05 and p = 0.025, respectively) with a negative immunostaining. We conclude that TTIp presented anti-TNF-α activity and an improved lipid profile of Wistar rats with dyslipidemia and obesity induced by a high glycemic index and load diet regardless of PPAR-γ induction.


  • Open Access

    Proteínas bioativas das sementes de tamarindo reduzem leptina plasmática independente da perda de peso em ratos com obesidade

    by Ana Heloneida De Araújo Morais, Izael De Sousa Costa, Fabiana Maria Coimbra de Carvalho

    Introdução: A obesidade caracteriza-se pelo acúmulo excessivo de gordura corporal, sendo essa responsável por elevadas concentrações de leptina. Pesquisas têm procurado adjuvantes no seu tratamento e as proteínas isoladas das sementes de tamarindo tem se destacado por possuírem atividades anti-obesidade e anti-inflamatória. Objetivos: Avaliar o efeito das proteínas de tamarindo sobre o peso, o índice de Lee e a concentração plasmática de leptina em ratos Wistar com obesidade. Metodologia: Utilizaram-se três grupos (n=5) de ratos Wistar, adultos, machos e com obesidade (Índice de Lee ≥ 300). As proteínas isoladas foram oferecidas durante 10 dias, por gavagem, aos animais do grupo teste. Ao grupo com tratamento convencional foi ofertada uma dieta padrão. Os animais do terceiro grupo receberam dieta de alto índice glicêmico e carga glicêmica, a mesma utilizada para indução da obesidade. No primeiro e no décimo dia de experimento, aferiu-se o peso e foi medido o comprimento caudal dos animais para avaliação do índice de Lee. Após a eutanásia, coletou-se sangue para dosagem de leptina. Resultados: O índice de Lee e o peso não sofreram influência em ambos os tratamentos (proteínas e dieta padrão). Entretanto, as proteínas provocaram uma discreta redução do Índice de Lee [0.312 (6,1) para 0.311 (4,3)], e do peso [402 g (38.6) para 400 g (35.7)]. Quanto a dosagem de leptina, 60% dos animais do grupo teste apresentaram redução de leptina (< 0,1ng/mL). Conclusão: As proteínas isoladas de tamarindo reduziram a leptina plasmática independente da perda de peso em ratos com obesidade, despontando como promissoras no estudo do tratamento da obesidade.


  • Open Access

    ATIVIDADE ANTITRÍPTICA EM SEMENTE E PRODUTO ALIMENTÍCIO DE CHIA (SALVIA HISPANICA L.)

    by Ana Paula Araújo De Souza, Lorena Maria Araújo Marinheiro Nascimento, Vanessa Cristina Oliveira De Lima, Fabiana Maria Coimbra De Carvalho, Elizeu Antunes Dos Santos, Ana Heloneida De Araújo Morais


  • Open Access

    A Trypsin Inhibitor from Tamarind Reduces Food Intake and Improves Inflammatory Status in Rats with Metabolic Syndrome Regardless of Weight Loss

    by Fabiana M. C. Carvalho, Vanessa C. O. Lima, Izael S. Costa, Amanda F. Medeiros, Alexandre C. Serquiz, Maíra C. J. S. Lima, Raphael P. Serquiz, Bruna L. L. Maciel, Adriana F. Uchôa, Elizeu A. Santos, et al.

    Trypsin inhibitors are studied in a variety of models for their anti-obesity and anti-inflammatory bioactive properties. Our group has previously demonstrated the satietogenic effect of tamarind seed trypsin inhibitors (TTI) in eutrophic mouse models and anti-inflammatory effects of other trypsin inhibitors. In this study, we evaluated TTI effect upon satiety, biochemical and inflammatory parameters in an experimental model of metabolic syndrome (MetS). Three groups of n = 5 male Wistar rats with obesity-based MetS received for 10 days one of the following: (1) Cafeteria diet; (2) Cafeteria diet + TTI (25 mg/kg); and (3) Standard diet. TTI reduced food intake in animals with MetS. Nevertheless, weight gain was not different between studied groups. Dyslipidemia parameters were not different with the use of TTI, only the group receiving standard diet showed lower very low density lipoprotein (VLDL) and triglycerides (TG) (Kruskal–Wallis, p < 0.05). Interleukin-6 (IL-6) production did not differ between groups. Interestingly, tumor necrosis factor-alpha (TNF-α) was lower in animals receiving TTI. Our results corroborate the satietogenic effect of TTI in a MetS model. Furthermore, we showed that TTI added to a cafeteria diet may decrease inflammation regardless of weight loss. This puts TTI as a candidate for studies to test its effectiveness as an adjuvant in MetS treatment.